NCEL
NewcelX Ltd. Ordinary Shares (NCEL)
Healthcare • NASDAQ • $3.36+3.70%
Key Fundamentals
- Symbol
- NCEL
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $3.36
- Daily Change
- +3.70%
- Market Cap
- $17.96M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $30.80
- 52W Low
- $1.83
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
About NewcelX Ltd. Ordinary Shares
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Company websiteResearch NCEL on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.